ACLS Provider: Course

Incorrect. Ventilations are delivered every 6-8 seconds to provide oxygenation without interrupting chest compressions.

Incorrect. The correct compression rate for CPR is 100-120 compressions per minute to optimize perfusion and prevent fatigue.

Incorrect. Epinephrine is administered to increase coronary and cerebral perfusion pressure during cardiac arrest.

Incorrect. Magnesium sulfate is administered to stabilize the myocardium and terminate torsades de pointes.

Incorrect. Asystole is a non-shockable rhythm and is treated with high-quality CPR and epinephrine administration.

Incorrect. Amiodarone 300 mg IV/IO is administered after defibrillation and epinephrine to treat refractory VF or pulseless VT.

Incorrect. Pulseless VT is a shockable rhythm requiring immediate defibrillation to restore an organized rhythm.

Incorrect. Immediate defibrillation is the most effective intervention for a witnessed cardiac arrest in VF.

Incorrect. Adequate oxygenation and ventilation are critical to preventing hypoxia or hyperoxia after ROSC.

Incorrect. Magnesium sulfate is used to treat torsades de pointes but is not the first-line drug for VF, where epinephrine is prioritized.

Incorrect. Compressions at 1/3 the depth of the chest ensure adequate perfusion while minimizing injury to internal organs.

Incorrect. Vagal maneuvers stimulate the vagus nerve, often terminating narrow-complex SVT caused by reentrant circuits.

Incorrect. Maintaining oxygen saturation at 92-96% avoids hypoxia while preventing hyperoxia, which can cause further tissue damage.

Incorrect. Epinephrine is administered after defibrillation to enhance coronary and cerebral perfusion during resuscitation.

Incorrect. IM epinephrine is the first-line treatment for anaphylaxis, administered into the mid-thigh for rapid absorption.

Incorrect. Epinephrine is administered every 3-5 minutes during cardiac arrest to maximize coronary and cerebral perfusion.

Incorrect. PEA is treated with CPR, epinephrine, and identifying reversible causes to restore organized electrical activity.

Incorrect. Asystole is a non-shockable rhythm treated with high-quality CPR and epinephrine.

Incorrect. Atropine is the first-line drug for symptomatic bradycardia, increasing heart rate by blocking vagal stimulation.

Incorrect. Early defibrillation within 30 seconds of a witnessed VF arrest increases survival rates significantly.

Incorrect. Post-ROSC care focuses on maintaining oxygenation and avoiding hypoxia or hyperoxia to protect organ function.

Incorrect. Naloxone is used to reverse opioid overdose, restoring respiratory effort in patients with respiratory depression.

Incorrect. Pediatric defibrillation begins at 2 J/kg and increases to 4 J/kg for subsequent shocks if needed.

Incorrect. Magnesium sulfate stabilizes the myocardium and is the first-line treatment for torsades de pointes.

Incorrect. Epinephrine is given as a continuous infusion to maintain adequate heart rate and perfusion when atropine is ineffective.

Incorrect. Dopamine is used when atropine is ineffective, improving heart rate and contractility by stimulating beta receptors.

Incorrect. While hypoglycemia can cause critical symptoms, it is not included in the H's and T's of reversible causes of cardiac arrest.

Incorrect. Early defibrillation is critical for survival, especially in shockable rhythms like VF/VT.

Incorrect. Asystole is a non-shockable rhythm requiring immediate high-quality CPR and administration of epinephrine.

Incorrect. Adenosine is administered at 0.1 mg/kg as a rapid IV push for terminating narrow-complex SVT caused by reentrant pathways.

Incorrect. PETCO2 monitoring provides real-time feedback on ventilation and the effectiveness of chest compressions.

Incorrect. Asystole is not a shockable rhythm; it is treated with high-quality CPR and epinephrine.

Incorrect. PEA is treated with CPR and epinephrine, as defibrillation is ineffective for non-shockable rhythms.

Incorrect. Chest compressions are performed to dislodge the obstruction and restore effective ventilation in an unresponsive infant.

Incorrect. A 15:2 ratio ensures efficient oxygenation and circulation in pediatric patients during two-rescuer CPR.

Incorrect. Thrombosis (pulmonary or coronary) is a reversible cause of cardiac arrest and should be addressed immediately.

Incorrect. PETCO2 monitoring helps assess the effectiveness of both ventilation and chest compressions in real-time during CPR.

Incorrect. Pediatric defibrillation starts with 2 J/kg, increasing to 4 J/kg for subsequent shocks if needed.

Incorrect. Prompt defibrillation within 30 seconds of witnessed VF arrest improves the chance of restoring a perfusing rhythm.

Incorrect. The 15:2 ratio improves oxygenation and circulation during high-quality infant CPR performed by two rescuers.

Incorrect. Adenosine is administered as a 6 mg rapid IV push, followed by a saline flush, to terminate reentrant arrhythmias.

Incorrect. Epinephrine at 0.01 mg/kg IV/IO is administered every 3-5 minutes to enhance coronary and cerebral perfusion in children.

Incorrect. Synchronized cardioversion is the treatment of choice for unstable ventricular tachycardia with a pulse.

Incorrect. TTM is used to reduce neurological injury post-ROSC by maintaining a core temperature of 32-36°C.

Incorrect. A 15:2 ratio is used during pediatric CPR with two rescuers to optimize ventilation and circulation.

Incorrect. Pulse checks during CPR should not exceed 10 seconds to minimize interruptions in chest compressions.

Incorrect. Epinephrine is dosed at 0.01 mg/kg IV/IO during pediatric cardiac arrest to improve coronary and cerebral perfusion.

Incorrect. Minimizing interruptions to less than 10 seconds preserves perfusion and improves resuscitation outcomes.

Incorrect. Asystole is a non-shockable rhythm requiring high-quality CPR and epinephrine administration.

Incorrect. Administered every 3-5 minutes to restore circulation by increasing coronary and cerebral perfusion pressure.

Incorrect. Calling for help ensures timely assistance and access to advanced resuscitation equipment.

Incorrect. Synchronized cardioversion at 100 J is effective for restoring a stable rhythm in unstable ventricular tachycardia.

Incorrect. A single rescuer performs 30 compressions followed by 2 breaths to maximize perfusion and oxygenation in pediatric CPR.

Incorrect. Hypothermia is a reversible cause of cardiac arrest and should be treated with warming measures.

Incorrect. The correct compression-to-ventilation ratio for adult CPR without an advanced airway is 30:2.

Incorrect. Oxygen saturation should be maintained at 92-96% to avoid hypoxia and reduce the risk of hyperoxia and oxidative stress.

Incorrect. Immediate defibrillation is critical for shockable rhythms like ventricular fibrillation and pulseless VT.

Incorrect. PEA is not treated with adenosine; it is managed with CPR, epinephrine, and identifying and treating reversible causes.

Incorrect. The two-thumb encircling technique provides high-quality compressions for infants during CPR.

Incorrect. Hypovolemia is a common reversible cause of PEA and should be addressed with rapid fluid resuscitation.

Incorrect. Amiodarone is used to stabilize wide-complex tachycardias in stable patients to prevent deterioration into cardiac arrest.

Incorrect. CPR should be resumed immediately after defibrillation to maintain perfusion and increase the likelihood of ROSC.

Incorrect. Biphasic defibrillators deliver effective shocks within the range of 120-200 J, restoring organized electrical activity.

Incorrect. A 30:2 ratio ensures sufficient oxygenation and circulation in adults during CPR without an advanced airway.

Incorrect. PETCO2 >10 mmHg during CPR indicates effective chest compressions generating sufficient circulation.